Zheng QF#, Xu B#*, Wang HM, Ding LH, Liu JY, Zhu LY, Qiu H, Zhang L, Ni GY, Ye J, Gao SB and Jin GH*. Epigenetic alterations contribute to promoter activity of imprinting gene IGF2. BBA -Gene Regulatory Mechanisms. 2018,1861(2):117-124;
Zheng QF#, Wang HM#, Wang ZF, Liu JY, Zhang Q, Zhang L, Lu YH, You H and Jin GH*. Reprogramming of histone methylation controls the differentiation of monocytes into macrophages. The FEBS Journal. 2017,284(9):1309-1323;
Zheng QF#, Han L#, Dong YC#, Tian J, Huang W, Liu ZY, Jia XZ, Jiang T, Zhang JN, Li X*, Kang CS*, Ren H*. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2 /STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma. Neuro-Oncology. 2014,16(9):1229-1243;
Gao SB, Zheng QF, Xu B, Pan CB, Li KL, Zhao Y, Zheng QL, Lin X, Xue LX and Jin GH*. EZH2 represses target genes through H3K27-dependent and H3K27-independent mechanisms in hepatocellular carcinoma. Molecular Cancer Research. 2014, 12: 1388-1397;
Gao SB#, Xu B#, Ding LH, Zheng QL, Zhang L, Zheng QF, Li SH, Feng ZJ, Wei J, Yin ZY, Hua X, Jin GH*. The functional and mechanistic relatedness of the EZH2 and menin in hepatocellular carcinoma. Journal of Hepatology. 2014, 61(4): 832-839;
Hu MH, Zheng QF, Jia XZ, Li Y, Dong YC, Wang CY, Lin QY, Zhang FY, Zhao RB, Xu HW, Zhou JH, Yuan HP, Zhang WH, Ren H*. Neuroprotection effect of interleukin (IL)-17 secreted by reactive astrocytes is emerged from a high-level IL-17-containing environment during acute neuroinflammation. Clin Exp Immunol. 2014, 175(2): 268-284;
Li X#*, Wang Q#, Zheng Y#, Lv S, Ning S, Sun J, Huang T, Zheng Q, Ren H, Xu J, Wang X, Li Y*. Prioritizing human cancer microRNAs based on genes' functional consistency between microRNA and cancer. Nucleic Acids Research. 2011, 39(22):e153.
Zheng QF#, Xu B#*, Wang HM, Ding LH, Liu JY, Zhu LY, Qiu H, Zhang L, Ni GY, Ye J, Gao SB and Jin GH*. Epigenetic alterations contribute to promoter activity of imprinting gene IGF2. BBA -Gene Regulatory Mechanisms. 2018,1861(2):117-124 DOI:10.1016/j.bbagrm.2017.12.007 PMID: 29413895
Zheng QF#, Wang HM#, Wang ZF, Liu JY, Zhang Q, Zhang L, Lu YH, You H and Jin GH*. Reprogramming of histone methylation controls the differentiation of monocytes into macrophages. The FEBS Journal. 2017,284(9):1309-1323 DOI: 10.1111/febs.14060 PMID: 28304152
Zheng QF#, Han L#, Dong YC#, Tian J, Huang W, Liu ZY, Jia XZ, Jiang T, Zhang JN, Li X*, Kang CS*, Ren H*. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2 /STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma. Neuro-Oncology. 2014,16(9):1229-1243 DOI: 10.1093/neuonc/nou046 PMID: 24861878 PMCID: PMC4136898
Gao SB, Zheng QF, Xu B, Pan CB, Li KL, Zhao Y, Zheng QL, Lin X, Xue LX and Jin GH*. EZH2 represses target genes through H3K27-dependent and H3K27-independent mechanisms in hepatocellular carcinoma. Molecular Cancer Research. 2014, 12: 1388-1397 DOI: 10.1158/1541-7786.MCR-14-0034 PMID: 24916103
Gao SB#, Xu B#, Ding LH, Zheng QL, Zhang L, Zheng QF, Li SH, Feng ZJ, Wei J, Yin ZY, Hua X, Jin GH*. The functional and mechanistic relatedness of the EZH2 and menin in hepatocellular carcinoma. Journal of Hepatology. 2014, 61(4): 832-839 DOI: 10.1016/j.jhep.2014.05.015 PMID: 24845612
Hu MH, Zheng QF, Jia XZ, Li Y, Dong YC, Wang CY, Lin QY, Zhang FY, Zhao RB, Xu HW, Zhou JH, Yuan HP, Zhang WH, Ren H*. Neuroprotection effect of interleukin (IL)-17 secreted by reactive astrocytes is emerged from a high-level IL-17-containing environment during acute neuroinflammation. Clin Exp Immunol. 2014, 175(2): 268-284 DOI: 10.1111/cei.12219 PMID: 24117055 PMCID: PMC3892418
Li X#*, Wang Q#, Zheng Y#, Lv S, Ning S, Sun J, Huang T, Zheng Q, Ren H, Xu J, Wang X, Li Y*. Prioritizing human cancer microRNAs based on genes' functional consistency between microRNA and cancer. Nucleic Acids Research. 2011, 39(22):e153 DOI: 10.1093/nar/gkr770 PMID: 21976726 PMCID: PMC3239203